Journals / Kulak Burun Boğaz İhtisas Dergisi / 2010 / Cilt: 20 - Sayı: 3

Astımlı ve astımlı olmayan nazal polipozisli hastaların nazal sekresyonlarındaki sitokin seviyeleri

Cytokine levels in nasal secretions in asthmatic and nonasthmatic patients with nasal polyposis

Pages
111–117
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results showed that the presence of Th2 cytokines, especially IL-5 and IL-6 in patients with NP and asthma is a prominent feature that relates to increased eosinophilic inflammation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to compare the cytokine levels of subjects with nasal polyps (NP) and comorbid asthma and NP patients without asthma.
📊
Key Findings & Data:Patients and Methods: Thirty patients with NP (15 asthmatic and 15 nonasthmatic) were included in this prospective study.
💡
Conclusion & Impact:Conclusion: Our results showed that the presence of Th2 cytokines, especially IL-5 and IL-6 in patients with NP and asthma is a prominent feature that relates to increased eosinophilic inflammation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to compare the cytokine levels of subjects with nasal polyps (NP) and comorbid asthma and NP patients without asthma. Patients and Methods: Thirty patients with NP (15 asthmatic and 15 nonasthmatic) were included in this prospective study. Nasal secretion samples were collected from the nasal cavities of all subjects. The levels of eleven cytokines (TNF-a, TNF-b, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, and IFN-g) were measured using flow cytometric method. Results: The concentrations of Th2 cytokines IL-5, IL-6 and IL-10 were significantly higher in patients with NP and asthma compared with subjects with NP without asthma. IFN-g, IL-4, IL-6 and IL-10 levels were found significantly higher in allergic patients with NP and asthma compared with those without asthma. In nonallergic patients with NP and asthma, the concentrations of TNF-a, IL-5 and IL-6 were significantly higher than in nonallergic patients with NP without asthma. Conclusion: Our results showed that the presence of Th2 cytokines, especially IL-5 and IL-6 in patients with NP and asthma is a prominent feature that relates to increased eosinophilic inflammation. We also found significant influence of asthma and allergy on the cytokine profiles in nasal secretions of patients with NP.

Özet

Amaç: Bu çalışmada nazal polip (NP)’leri ve hastalığa eşlik eden astımı olan ve olmayan NP’li hastaların sitokin seviyeleri karşılaştırıldı. Hastalar ve Yöntemler: Bu ileriye yönelik çalışmaya, nazal polipleri olan 30 hasta (15 astımlı ve 15 astımlı olmayan) dahil edildi. Tüm olguların nazal kavitelerinden nazal sekresyon örnekleri biriktirildi. On bir sitokinin (TNF-a, TNF-b, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 ve IFN-g) seviyeleri akım sitometri yöntemi ile ölçüldü. Bulgular: Th2 sitokinlerinin IL-5, IL-6 ve IL-10 konsantrasyonları astımı olan NP’li hastalarda, astımı olmayan NP’li hastalara göre anlamlı derecede yüksek bulundu. Nazal polipli ve astımı olan alerjik hastalarda, IFN-g, IL-4, IL-6 ve IL-10 seviyeleri, astımı olmayanlara göre anlamlı derecede yüksek bulundu. Alerjik olmayan, nazal polipleri ve astımı olan hastalarda TNF-a, IL-5 ve IL-6 konsantrasyonları, alerjisi ve astımı olmayan NP’li hastalara göre oldukça yüksek bulundu. Sonuç: Bizim sonuçlarımıza göre, Th2 sitokinlerinin, özellikle de IL-5 ve IL-6’nın varlığı, NP ve astımı olan hastalarda eozinofilik inflamasyonun artışıyla ilişkili belirgin bir özelliktir. Biz aynı zamanda astım ve alerjinin, NP’li hastaların nazal sekresyonlarındaki sitokin profiline önemli etkisinin olduğunu saptadık.

🔖

Cite This Article

PERIC, A., VOJVODIC, D., RADULOVIC, V., MILJANOVIC, O. (2010). Astımlı ve astımlı olmayan nazal polipozisli hastaların nazal sekresyonlarındaki sitokin seviyeleri. Kulak Burun Boğaz İhtisas Dergisi, Cilt: 20 - Sayı: 3, 111–117. https://ajindex.com/articles/343262

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007;20:1-136
  2. Erbek SS, Yurtcu E, Erbek S, Atac FB, Sahin FI, Cakmak O. Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg 2007;133:705-9
  3. Ramanathan M Jr, Lee WK, Spannhake EW, Lane AP. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol 2008;22:115-21
  4. Král B, Krejsek J, Paráková Z, Kopecky´ O, Vokurková D, Derner V, et al. Some serum activity markers of airways inflammation in difficult-to-control asthma patients. Acta Medica (Hradec Kralove) 1997;40:61-70
  5. Jankowski R, Persoons M, Foliguet B, Coffinet L, Thomas C, Verient-Montaut B. Eosinophil count in nasal secretions of subjects with and without nasal symptoms. Rhinology 2000;38:23-32
  6. Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl D, Bürner H. Nasal biomarker profiles in acute and chronic rhinosinusitis. Clin Exp Allergy 2005;35:1186-91
  7. Riechelmann H, Deutschle T, Friemel E, Gross HJ, Bachem M. Biological markers in nasal secretions. Eur Respir J 2003;21:600-5
  8. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy 2000;30 Suppl 1:2-5
  9. Tsicopoulos A, Shimbara A, de Nadai P, Aldewachi O, Lamblin C, Lassalle P, et al. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol 2004;113:462-9
  10. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg 1997;123:595-600
  11. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology 1993;31:183-4
  12. Watelet JB, Gevaert P, Holtappels G, Van Cauwenberge P, Bachert C. Collection of nasal secretions for immunological analysis. Eur Arch Otorhinolaryngol 2004; 261:242-6
  13. Bachert C, van Kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999; 118:375-9
  14. Ohkubo K, Ikeda M, Pawankar R, Gotoh M, Yagi T, Okuda M. Mechanisms of IL-6, IL-8, and GM-CSF release in nasal secretions of allergic patients after nasal challenge. Rhinology 1998;36:156-61
  15. Hens G, Hellings PW. The nose: gatekee